The vaccine, developed with the University of Oxford, showed an average efficacy of 70% in preventing the coronavirus, according to the company. However, that is an average of two dosing regimens — one involving two full doses at least a month apart that proved to be 62% effective. A second regimen, involving a half dose followed by a full does at least one month later was 90% effective, the company said.
@Sweetchocalates Wrong, Cansino does not use the same tech as moderna or pfizer. It uses the same tech as Johson & Johnson and Astrazeneca/Oxford (Today reported average 70% efficacy). The vaccine tech is adenovirus vector vaccine.
Oh ya...oops lol. I was confused as the mechanism of adenovirus and mRNA technology seems similar in that they use the genetic code of the virus to trigger an immune response from the body. Difference is that mRNA uses a fragment of the virus while adeno uses a whole virus?
Ditanya sama ada BN akan kekal memberi sokongan kepada Belanjawan 2021 secara bersyarat seperti yang diumumkan sebelum ini, Hishamuddin berkata, itu adalah keputusan parti setakat ini.
Solutn management also said the fill and finish facility will be used for other vacinnes (not related to covid) if covid vacinne is not approved. But i dont think shareholders view hat favourably if cansino vacinne s not approved by msia gomen.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
DickyMe
14,887 posts
Posted by DickyMe > 2020-11-23 19:47 | Report Abuse
@lee9fold
If I am a clown then you are a joker!
If I am a joker then you are the clown!
Either way you are still a laughing stock!
LOLOLOL.